T-Cell Lymphoma

This study is for males and females age 18 years or older with confirmed diagnosis of Peripheral T-Cell Lymphoma. Patients must have relapsed after at least one prior anticancer regimen. Labs will  be taken to determine adequate organ function for study participation.